Increased Labyrinthine T1 Postgadolinium Signal Intensity is Associated with the Degree of Ipsilateral Sensorineural Hearing Loss in Patients with Sporadic Vestibular Schwannoma

References

1. 1.↵
   1. Marinelli JP,
   2. Lohse CM,
   3. Carlson ML

   . Incidence of vestibular schwannoma over the past half-century: a population-based study of Olmsted County, Minnesota. Otolaryngol Head Neck Surg 2018;159:717–23 doi:10.1177/0194599818770629 pmid:29712512

   CrossRefPubMed
2. 2.↵
   1. Reznitsky M,
   2. Petersen MM,
   3. West N, et al

   . Epidemiology of vestibular schwannomas: prospective 40-year data from an unselected national cohort. Clin Epidemiol 2019;11:981–86 doi:10.2147/CLEP.S218670 pmid:31807080

   CrossRefPubMed
3. 3.↵
   1. Floc’h JL,
   2. Tan W,
   3. Telang RS, et al

   . Markers of cochlear inflammation using MRI. J Magn Reson Imaging 2014;39:150–61 doi:10.1002/jmri.24144 pmid:23589173

   CrossRefPubMed
4. 4.↵
   1. Hannan CJ,
   2. Lewis D,
   3. O’Leary C, et al

   . The inflammatory microenvironment in vestibular schwannoma. Neurooncol Adv 2020;2:vdaa023 doi:10.1093/noajnl/vdaa023 pmid:32642684

   CrossRefPubMed
5. 5.↵
   1. Lassaletta L,
   2. Calvino M,
   3. Morales-Puebla JM, et al

   . Biomarkers in vestibular schwannoma–associated hearing loss. Front Neurol 2019;10:978 doi:10.3389/fneur.2019.00978 pmid:31620068

   CrossRefPubMed
6. 6.↵
   1. Naganawa S,
   2. Koshikawa T,
   3. Nakamura T, et al

   . High-resolution T1-weighted 3D real IR imaging of the temporal bone using triple-dose contrast material. Eur Radiol 2003;13:2650–58 doi:10.1007/s00330-003-1922-8 pmid:12734671

   CrossRefPubMed
7. 7.↵
   1. Naganawa S,
   2. Komada T,
   3. Fukatsu H, et al

   . Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006;16:733–37 doi:10.1007/s00330-005-0046-8 pmid:16267664

   CrossRefPubMed
8. 8.↵
   1. Yamazaki M,
   2. Naganawa S,
   3. Kawai H, et al

   . Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009;51:855–63 doi:10.1007/s00234-009-0588-6 pmid:19727694

   CrossRefPubMed
9. 9.↵
   1. Bowen AJ,
   2. Carlson ML,
   3. Lane JI

   . Inner ear enhancement with delayed 3D-FLAIR MRI imaging in vestibular schwannoma. Otol Neurotol 2020;41:1274–79 doi:10.1097/MAO.0000000000002768 pmid:32925857

   CrossRefPubMed
10. 10.↵
    1. Patel NS,
    2. Huang AE,
    3. Dowling EM, et al

    . The influence of vestibular schwannoma tumor volume and growth on hearing loss. Otolaryngol Head Neck Surg 2020;162:530–37 doi:10.1177/0194599819900396 pmid:31986971

    CrossRefPubMed
11. 11.↵
    1. Lees KA,
    2. Tombers NM,
    3. Link MJ, et al

    . Natural history of sporadic vestibular schwannoma: a volumetric study of tumor growth. Otolaryngol Head Neck Surg 2018;159:535–42 doi:10.1177/0194599818770413 pmid:29685084

    CrossRefPubMed
12. 12.↵
    Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg 1995;113:179–80 doi:10.1016/S0194-5998(95)70101-X pmid:7675475

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Gurgel RK,
    2. Popelka GR,
    3. Oghalai JS, et al

    . Is it valid to calculate the 3-kilohertz threshold by averaging 2 and 4 kilohertz? Otolaryngol Head Neck Surg 2012;147:102–04 doi:10.1177/0194599812437156 pmid:22301102

    CrossRefPubMed
14. 14.↵
    1. Naganawa S,
    2. Koshikawa T,
    3. Nakamura T, et al

    . Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3 T. Eur Radiol 2004;14:1901–08 doi:10.1007/s00330-004-2372-7 pmid:15221269

    CrossRefPubMed
15. 15.↵
    1. Osawa I,
    2. Kozawa E,
    3. Tanaka S, et al

    . Signal and morphological changes in the endolymph of patients with vestibular schwannoma on non-contrast 3D FLAIR at 3 Tesla. BMC Med Imaging 2021;21:135 doi:10.1186/s12880-021-00670-9 pmid:34563164

    CrossRefPubMed
16. 16.↵
    1. Bhadelia RA,
    2. Tedesco KL,
    3. Hwang S, et al

    . Increased cochlear fluid-attenuated inversion recovery signal in patients with vestibular schwannoma. AJNR Am J Neuroradiol 2008;29:720–23 doi:10.3174/ajnr.A0968 pmid:18238842

    CrossRefPubMed
17. 17.↵
    1. Kim DY,
    2. Lee JH,
    3. Goh MJ, et al

    . Clinical significance of an increased cochlear 3D fluid-attenuated inversion recovery signal intensity on an MR imaging examination in patients with acoustic neuroma. AJNR Am J Neuroradiol 2014;35:1825–29 doi:10.3174/ajnr.A3936 pmid:24742808

    Abstract/FREE Full Text
18. 18.↵
    1. Yoshida T,
    2. Sugiura M,
    3. Naganawa S, et al

    . Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings and prognosis in sudden sensorineural hearing loss. Laryngoscope 2008;118:1433–37 doi:10.1097/MLG.0b013e318172ef85 pmid:18475208

    CrossRefPubMedWeb of Science
19. 19.↵
    1. van de Langenberg R,
    2. de Bondt BJ,
    3. Nelemans PJ, et al

    . Predictors of volumetric growth and auditory deterioration in vestibular schwannomas followed in a wait and scan policy. Otol Neurotol 2011;32:338–44 doi:10.1097/MAO.0b013e3182040d9f pmid:21150682

    CrossRefPubMed
20. 20.↵
    1. Luong PQ,
    2. Cabrera CI,
    3. Patil N, et al

    . MRI T2-weighted cochlear intensity as a predictor of hearing loss with vestibular schwannoma patients. Ann Otol Neurotol 2021;4:19–25 doi:10.1055/s-0041-1735394

    CrossRef
21. 21.↵
    1. van Linge A,
    2. Borsboom GJ,
    3. Wieringa MH, et al

    . Hearing loss progresses faster in patients with growing intracanalicular vestibular schwannomas. Otol Neurotol 2016;37:1442–48 doi:10.1097/MAO.0000000000001190 pmid:27579837

    CrossRefPubMed
22. 22.↵
    1. Brown A,
    2. Early S,
    3. Vasilijic S, et al

    . Sporadic vestibular schwannoma size and location do not correlate with the severity of hearing loss at initial presentation. Front Oncol 2022;12:836504 doi:10.3389/fonc.2022.836504 pmid:35372070

    CrossRefPubMed
23. 23.↵
    1. Luryi AL,
    2. Babu S,
    3. Bojrab DI, et al

    . Progression of hearing loss in observed non-growing vestibular schwannoma. Otol Neurotol 2022;43:e767–72 doi:10.1097/MAO.0000000000003563 pmid:35763454

    CrossRefPubMed
24. 24.↵
    1. Saba ES,
    2. Marinelli JP,
    3. Lohse CM, et al

    . Quantifying tertiary referral center bias in vestibular schwannoma research. Otol Neurotol 2020;41:258–64 doi:10.1097/MAO.0000000000002496 pmid:31789811

    CrossRefPubMed